Vistagen Therapeutics, Inc. (VTGN)
0.5866
-0.01
(-2.33%)
USD |
NASDAQ |
Apr 02, 16:00
0.5899
0.00 (0.00%)
After-Hours: 20:00
Vistagen Therapeutics Shareholders Equity (Quarterly) : 50.92M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Alector, Inc. | 30.65M |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Savara, Inc. | 203.13M |
| BioMarin Pharmaceutical, Inc. | 6.087B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 65.06M |
| Total Liabilities (Quarterly) | 14.14M |
| Debt to Equity Ratio | 0.028 |
| Current Ratio | 4.675 |
| Net Debt Paydown Yield | 0.43% |